- Home
- NATL vs NVCR Comparison
NATL vs NVCR Comparison
Compare NATL & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATL
- NVCR
- Stock Information
- Founded
- NATL 2023
- NVCR 2000
- Country
- NATL United States
- NVCR Switzerland
- Employees
- NATL N/A
- NVCR N/A
- Industry
- NATL
- NVCR Medical/Dental Instruments
- Sector
- NATL
- NVCR Health Care
- Exchange
- NATL Nasdaq
- NVCR Nasdaq
- Market Cap
- NATL 2.2B
- NVCR 1.9B
- IPO Year
- NATL N/A
- NVCR 2015
- Fundamental
- Price
- NATL $27.55
- NVCR $16.51
- Analyst Decision
- NATL Buy
- NVCR Buy
- Analyst Count
- NATL 4
- NVCR 7
- Target Price
- NATL $38.75
- NVCR $32.43
- AVG Volume (30 Days)
- NATL 571.6K
- NVCR 1.1M
- Earning Date
- NATL 08-06-2025
- NVCR 07-24-2025
- Dividend Yield
- NATL N/A
- NVCR N/A
- EPS Growth
- NATL N/A
- NVCR N/A
- EPS
- NATL 1.55
- NVCR N/A
- Revenue
- NATL $4,247,000,000.00
- NVCR $621,711,000.00
- Revenue This Year
- NATL $1.81
- NVCR $5.44
- Revenue Next Year
- NATL $4.41
- NVCR $9.05
- P/E Ratio
- NATL $17.77
- NVCR N/A
- Revenue Growth
- NATL N/A
- NVCR 18.27
- 52 Week Low
- NATL $22.30
- NVCR $14.17
- 52 Week High
- NATL $35.50
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- NATL 46.20
- NVCR 43.87
- Support Level
- NATL $29.41
- NVCR $15.90
- Resistance Level
- NATL $28.23
- NVCR $18.59
- Average True Range (ATR)
- NATL 1.12
- NVCR 0.63
- MACD
- NATL -0.29
- NVCR -0.13
- Stochastic Oscillator
- NATL 25.83
- NVCR 22.72
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.